Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
<p><br></p><p dir="ltr">Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a c...
محفوظ في:
| المؤلف الرئيسي: | Mohamad Y. Khatib (11659459) (author) |
|---|---|
| مؤلفون آخرون: | Solaiman M. Allafi (14777275) (author), Abdulqadir J. Nashwan (11659453) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Mitigating Motion Sickness in Autonomous Vehicles for Improved Passenger Comfort
حسب: Wadi, Ali
منشور في: (2024) -
Driving simulation sickness and the sense of presence: Correlation and contributing factors
حسب: Mustafa Almallah (17280568)
منشور في: (2021) -
Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
حسب: Lina Okar (14777164)
منشور في: (2023) -
Rituximab and Pirfenidone in the Treatment of Steroid‐Refractory Bleomycin Lung Injury
حسب: Aasir M. Suliman (14150217)
منشور في: (2025) -
Prevalence and risk factors of poor indoor air quality and sick house syndrome symptoms in Dubai
حسب: ALI, MUNA IBRAHIM
منشور في: (2019)